US Stock MarketDetailed Quotes
OLMA Olema Pharmaceuticals
- 9.950
- +0.120+1.22%
Close Apr 26 16:00 ET
- 9.520
- -0.430-4.32%
Post 19:14 ET
556.54MMarket Cap-4649P/E (TTM)
10.090High9.510Low434.48KVolume9.870Open9.830Pre Close4.29MTurnover1.53%Turnover RatioLossP/E (Static)55.93MShares17.79152wk High2.19P/B283.47MFloat Cap4.60052wk Low--Dividend TTM28.49MShs Float60.270Historical High--Div YieldTTM5.90%Amplitude2.000Historical Low9.864Avg Price1Lot Size
Olema Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -2.03%-83.73M | 6.27%-18.48M | -26.41%-22.74M | 16.41%-22.12M | -13.90%-20.39M | -61.90%-82.07M | -5.96%-19.71M | -48.72%-17.99M | -197.13%-26.46M | -61.52%-17.9M |
| Net income from continuing operations | 7.76%-96.66M | -2.27%-26.77M | 5.36%-21.5M | 38.84%-20.1M | -22.82%-28.29M | -47.39%-104.79M | -20.99%-26.18M | -28.27%-22.72M | -100.28%-32.86M | -50.14%-23.03M |
| Operating gains losses | --111K | --0 | --103K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 5.60%377K | -9.28%88K | -1.10%90K | 16.47%99K | 19.05%100K | 119.02%357K | 32.88%97K | 82.00%91K | 174.19%85K | 833.33%84K |
| Other non cash items | -922.37%-4.23M | -1,027.98%-5.2M | -2.14%320K | 0.31%326K | 1.24%327K | -58.01%514K | ---461K | --327K | --325K | --323K |
| Change In working capital | -119.49%-589K | 230.71%5.8M | -2,135.11%-4.58M | -526.99%-5.52M | 1,576.89%3.71M | 6.78%3.02M | 159.59%1.76M | -83.03%225K | -62.79%1.29M | -125.77%-251K |
| -Change in prepaid assets | 135.43%694K | 119.85%401K | 16.08%-120K | -2,043.75%-622K | 501.74%1.04M | -4,797.50%-1.96M | -58.81%-2.02M | -140.40%-143K | -94.55%32K | -40.89%172K |
| -Change in payables and accrued expense | 562.11%2.32M | 36.39%491K | 649.06%582K | 737.84%944K | 25.31%307K | 151.39%351K | 330.77%360K | 48.29%-106K | -3,060.00%-148K | 174.92%245K |
| -Change in other current assets | -377.92%-5.32M | --4K | -808.22%-5.2M | 55.96%-133K | --0 | -3,613.33%-1.11M | --0 | ---572K | ---302K | ---240K |
| -Change in other current liabilities | -70.11%1.72M | 43.72%4.91M | -85.28%154K | -433.72%-5.71M | 652.57%2.37M | 60.31%5.74M | 329.66%3.42M | -11.13%1.05M | -40.65%1.71M | -142.38%-428K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -2.03%-83.73M | 6.27%-18.48M | -26.41%-22.74M | 16.41%-22.12M | -13.90%-20.39M | -61.90%-82.07M | -5.96%-19.71M | -48.72%-17.99M | -197.13%-26.46M | -61.52%-17.9M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -105.30%-4.85M | -289.24%-30.92M | -226.15%-25.44M | -52.02%14.11M | 46.23%37.39M | 133.21%91.48M | 172.27%16.34M | 257.73%20.16M | 169.09%29.41M | 109.14%25.57M |
| Net PPE purchase and sale | 103.86%14K | --0 | 110.07%14K | --0 | --0 | 76.95%-363K | 75.25%-173K | -44.79%-139K | 94.17%-21K | 92.86%-30K |
| Net investment purchase and sale | -105.30%-4.87M | -287.26%-30.92M | -225.35%-25.45M | -52.05%14.11M | 46.06%37.39M | 133.54%91.84M | 146.44%16.51M | 260.02%20.3M | 160.70%29.43M | 109.17%25.6M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -105.30%-4.85M | -289.24%-30.92M | -226.15%-25.44M | -52.02%14.11M | 46.23%37.39M | 133.21%91.48M | 172.27%16.34M | 257.73%20.16M | 169.09%29.41M | 109.14%25.57M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 27,928.36%133.42M | 91.58%523K | 123,134.91%130.63M | 3,092.19%2.04M | 566.67%220K | -65.78%476K | -66.63%273K | 85.96%106K | -87.60%64K | 33K |
| Net common stock issuance | --129.74M | ---24K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | 672.90%3.68M | 100.37%547K | 719.81%869K | 3,092.19%2.04M | 566.67%220K | -65.78%476K | -66.63%273K | 85.96%106K | -87.60%64K | --33K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 27,928.36%133.42M | 91.58%523K | 123,134.91%130.63M | 3,092.19%2.04M | 566.67%220K | -65.78%476K | -66.63%273K | 85.96%106K | -87.60%64K | --33K |
| Net cash flow | ||||||||||
| Beginning cash position | 71.60%23.7M | 338.02%117.41M | 42.53%34.96M | 90.24%40.92M | 71.60%23.7M | -95.92%13.81M | 4.72%26.8M | -51.36%24.53M | -55.08%21.51M | -95.92%13.81M |
| Current changes in cash | 353.36%44.84M | -1,475.37%-48.87M | 3,519.36%82.45M | -297.55%-5.96M | 123.67%17.22M | 103.05%9.89M | 73.68%-3.1M | 109.18%2.28M | 18.73%3.02M | 102.65%7.7M |
| End cash Position | 189.17%68.54M | 189.17%68.54M | 338.02%117.41M | 42.53%34.96M | 90.24%40.92M | 71.60%23.7M | 71.60%23.7M | 4.72%26.8M | -51.36%24.53M | -55.08%21.51M |
| Free cash flow | -1.58%-83.73M | 7.08%-18.48M | -25.44%-22.74M | 16.48%-22.12M | -13.71%-20.39M | -57.71%-82.43M | -3.02%-19.88M | -48.69%-18.13M | -185.81%-26.48M | -55.88%-17.93M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg